Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novartis Announces New Phase 3 Study for Spinal Muscular Atrophy Treatment in Elderly Patients

americanpharmaceuticalreviewAugust 04, 2021

Tag: Novartis , sma , OAV-101 , STEER

PharmaSources Customer Service